Skip to main content

White paper

Toward outcomes-based payments

Learn from industry leaders in this report from Reuters Events Pharma.

Early engagement is the key to success

Work with Optum Life Sciences to demonstrate value through new payment models.

Related Content

Engage payers with value-based contracts

Assess the fit, develop metrics and track care outcomes over time.

Solve contract challenges for gene therapies

Gene therapies have the potential to be transformative, but there are hurdles to overcome for value-based contracts to become widespread.

How VBC can work for manufacturers

Value-based contracts can present challenges that must be overcome to bring gene therapies to market.